Excellent global clinical trial supply experts by clientpharma.com: We’re a specialist pharmaceutical supply company meeting global client requirements for clinical development. ClientPharma offers innovative sourcing and supply solutions from pre-clinical through to Phases I, II and III. Throughout the lifecycle of your drug development, it is our strategic approach that provides effective, tailored solutions that streamline the many complexities, avoiding supply chain disruptions and costly delays. See more information at https://www.clientpharma.com/risk-mitigation-and-competitiveness/.
We profoundly understand and recognize the numerous risks associated with global drug procurement. We also appreciate the many complexities associated with worldwide storage and distribution of clinical trial supplies. Our team knows the importance of an efficient, robust supply chain — audited & approved — that promotes excellence, security and accountability. We provide batch traceability, supporting documentation (i.e. Certificates of Analysis (CofAs), Batch Release Certificates (BRCs), GMP Statements, stability data, Fit-for-Use (FFU) Statements, Certificates of Conformance (CofCs), Certificates of Origin (CofOs), etc.) and temperature monitoring data – delivering product pedigree and authenticity.
From sample requests to global bulk supply procurement and distribution, we work as an extension of your team to guide you through the appropriate steps to mitigate risks. From start-to-finish, we utilize our extensive expertise and breadth of knowledge to navigate: Market Intelligence; Supply Chain Planning; Risk Management; Sourcing; Waste Management; Storage & Distribution; Documentation Management; Returns, Reconciliation & Destruction Services.
We are dedicated to delivering on point and on time, every time, no matter how technically challenging. With our preferred logistics partners, we offer warehousing solutions and specialist logistics to meet your clinical trial requirements. Global pharma warehousing and distribution capabilities: With our own state-of-the-art pharmaceutical warehouses strategically situated in major European and North American distribution hubs, as well as our global network of partner depots, ClientPharma provides you with your clinical trial supplies precisely where and when you need them. With access to our secure pharmaceutical warehousing, you can be confident in the integrity of your supply chain. All of our high-security storage conforms to strict cGDP guidelines. Find more details at https://www.clientpharma.com/.
Meeting the needs of global clinical supply trials requires diversity in supply strategies to address the unique complexities of each country’s healthcare and medication distribution systems. The “one-size fits all” approach is not a single supply strategy; instead, it leverages the expertise of a supply vendor partnership that addresses the need for a multi-faceted supply chain strategy. TrialCard Incorporated is a full-service life sciences commercialization partner that provides comprehensive solutions that span the entire biopharmaceutical value chain. In addition to a foundation of fully integrated, digitally enabled patient support services, its broader offerings include everything from late-stage clinical trial management to post-marketing HCP engagement services and proprietary data-as-a-service payer intelligence and insights. Founded in 2000, TrialCard provides commercialization needs for more than 160 life science customers and has connected over 35 million patients with more than $18 billion in branded drug savings to date. The company is headquartered in Morrisville, North Carolina.
Supply and demand of pharmaceuticals are mutually exclusive. The supply chain is wholly reliant upon pharmaceutical companies being able to effectively forecast demand for a particular product. The process of forecasting is often made difficult when a new medicine has just been brought to market or rapid deployment of a drug needs to happen in response to a pandemic due to a lack of concrete evidence to base estimations on. In a survey of pharmaceutical Senior Managers it was reported that the majority of pharmaceutical companies had miscalculated demand for new medicines by up to 25%. Michael Lehmann, executive vice president of sales and marketing for Patheon, a global provider of outsourced pharmaceutical development and manufacturing said, “Making accurate demand forecasts is extremely challenging for pharmaceutical companies”.